These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 10405653

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Occurrence of thanatophoric dysplasia type I (R248C) and hypochondroplasia (N540K) mutations in two patients with achondroplasia phenotype.
    Camera G, Baldi M, Strisciuglio G, Concolino D, Mastroiacovo P, Baffico M.
    Am J Med Genet; 2001 Dec 15; 104(4):277-81. PubMed ID: 11754059
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Molecular basis of achondroplasia, hypochondroplasia, and thanatophoric dysplasia].
    Moskalewski S, Hyc A, Osiecka-Iwan A, Strzelczyk P.
    Chir Narzadow Ruchu Ortop Pol; 2000 Dec 15; 65(3):327-33. PubMed ID: 11057021
    [Abstract] [Full Text] [Related]

  • 7. Achondroplasia, hypochondroplasia and thanatophoric dysplasia: clinically related skeletal dysplasias that are also related at the molecular level.
    Cohen MM.
    Int J Oral Maxillofac Surg; 1998 Dec 15; 27(6):451-5. PubMed ID: 9869286
    [Abstract] [Full Text] [Related]

  • 8. [From gene to disease; achondroplasia and other skeletal dysplasias due to an activating mutation in the fibroblast growth factor].
    van Ravenswaaij-Arts CM, Losekoot M.
    Ned Tijdschr Geneeskd; 2001 Jun 02; 145(22):1056-9. PubMed ID: 11414167
    [Abstract] [Full Text] [Related]

  • 9. C-type natriuretic peptide plasma levels are elevated in subjects with achondroplasia, hypochondroplasia, and thanatophoric dysplasia.
    Olney RC, Prickett TC, Espiner EA, Mackenzie WG, Duker AL, Ditro C, Zabel B, Hasegawa T, Kitoh H, Aylsworth AS, Bober MB.
    J Clin Endocrinol Metab; 2015 Feb 02; 100(2):E355-9. PubMed ID: 25387261
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prenatal diagnosis of thanatophoric dysplasia in the second trimester: ultrasonography and other diagnostic modalities.
    Sahinoglu Z, Uludogan M, Gurbuz A, Karateke A.
    Arch Gynecol Obstet; 2003 Nov 02; 269(1):57-61. PubMed ID: 14605823
    [Abstract] [Full Text] [Related]

  • 12. Bone dysplasias: an introduction.
    Azouz EM, Teebi AS, Eydoux P, Chen MF, Fassier F.
    Can Assoc Radiol J; 1998 Apr 02; 49(2):105-9. PubMed ID: 9561013
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical and molecular diagnosis of the skeletal dysplasias associated with mutations in the gene encoding Fibroblast Growth Factor Receptor 3 (FGFR3) in Portugal.
    Almeida MR, Campos-Xavier AB, Medeira A, Cordeiro I, Sousa AB, Lima M, Soares G, Rocha M, Saraiva J, Ramos L, Sousa S, Marcelino JP, Correia A, Santos HG.
    Clin Genet; 2009 Feb 02; 75(2):150-6. PubMed ID: 19215249
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Achondroplasia: Development, pathogenesis, and therapy.
    Ornitz DM, Legeai-Mallet L.
    Dev Dyn; 2017 Apr 02; 246(4):291-309. PubMed ID: 27987249
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.